Literature DB >> 1889920

A comparison of the effects of single- and split-dose methadone administration on the fetus: ultrasound evaluation.

B K Wittmann1, S Segal.   

Abstract

A prospective study was conducted to evaluate the effects of oral methadone on fetal activity (body movements, breathing, longest inactive period) for drug-dependent pregnant women on methadone maintenance. Seven consenting drug-dependent pregnant women between 26 and 37 weeks gestation were enrolled in the study. Pairs of ultrasound observation studies were conducted, before and after single-dose methadone (SDM) treatment and split-dose methadone treatment. There were significant decreases in both body movements (p less than 0.001) and breathing episodes (p less than 0.01), and a significant increase in the longest period of inactivity (p less than 0.001) following SDM. A similar but not significant trend was noted before and after split-dose methadone. The results of the single-dose studies differed significantly from normal controls. However, the results of the split-dose studies were similar to controls. It is recommended that women on methadone maintenance should be offered a split-dose treatment protocol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889920     DOI: 10.3109/10826089109053183

Source DB:  PubMed          Journal:  Int J Addict        ISSN: 0020-773X


  11 in total

Review 1.  Pharmacological Management of Opioid Use Disorder in Pregnant Women.

Authors:  Christine M Wilder; Theresa Winhusen
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

Review 2.  Pregnancy and injecting drug use.

Authors:  James Bell; Lucy Harvey-Dodds
Journal:  BMJ       Date:  2008-06-07

3.  Maternal methadone dosing schedule and fetal neurobehaviour.

Authors:  Lauren M Jansson; Janet A Dipietro; Martha Velez; Andrea Elko; Heather Knauer; Katie T Kivlighan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-01

4.  Fetal assessment before and after dosing with buprenorphine or methadone.

Authors:  Amy L Salisbury; Mara G Coyle; Kevin E O'Grady; Sarah H Heil; Peter R Martin; Susan M Stine; Karol Kaltenbach; Manfred Weninger; Hendrée E Jones
Journal:  Addiction       Date:  2012-11       Impact factor: 6.526

Review 5.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14

Review 6.  Changing Outdated Methadone Regulations That Harm Pregnant Patients.

Authors:  John J McCarthy; Hendree E Jones; Mishka Terplan; Vania P Rudolf; Melinda Campopiano von Klimo
Journal:  J Addict Med       Date:  2021-04-01       Impact factor: 3.702

7.  Prenatal methadone exposure is associated with altered neonatal brain development.

Authors:  Victoria J Monnelly; Devasuda Anblagan; Alan Quigley; Manuel Blesa Cabez; E Sarah Cooper; Helen Mactier; Scott I Semple; Mark E Bastin; James P Boardman
Journal:  Neuroimage Clin       Date:  2017-12-24       Impact factor: 4.881

8.  Opioid use disorder in pregnancy.

Authors:  Kristin Harter
Journal:  Ment Health Clin       Date:  2019-11-27

9.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

Review 10.  Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.

Authors:  Barbara K Zedler; Ashley L Mann; Mimi M Kim; Halle R Amick; Andrew R Joyce; E Lenn Murrelle; Hendrée E Jones
Journal:  Addiction       Date:  2016-06-30       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.